rs148632119

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_022124.6(CDH23):​c.5541C>T​(p.Asn1847=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00168 in 1,614,072 control chromosomes in the GnomAD database, including 28 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0014 ( 3 hom., cov: 34)
Exomes 𝑓: 0.0017 ( 25 hom. )

Consequence

CDH23
NM_022124.6 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -1.90
Variant links:
Genes affected
CDH23 (HGNC:13733): (cadherin related 23) This gene is a member of the cadherin superfamily, whose genes encode calcium dependent cell-cell adhesion glycoproteins. The encoded protein is thought to be involved in stereocilia organization and hair bundle formation. The gene is located in a region containing the human deafness loci DFNB12 and USH1D. Usher syndrome 1D and nonsyndromic autosomal recessive deafness DFNB12 are caused by allelic mutations of this cadherin-like gene. Upregulation of this gene may also be associated with breast cancer. Alternative splice variants encoding different isoforms have been described. [provided by RefSeq, May 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant 10-71784929-C-T is Benign according to our data. Variant chr10-71784929-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 45985.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-71784929-C-T is described in Lovd as [Benign]. Variant chr10-71784929-C-T is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-1.9 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.00141 (215/152360) while in subpopulation SAS AF= 0.0216 (104/4824). AF 95% confidence interval is 0.0182. There are 3 homozygotes in gnomad4. There are 125 alleles in male gnomad4 subpopulation. Median coverage is 34. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 3 AD,AR,Digenic gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CDH23NM_022124.6 linkuse as main transcriptc.5541C>T p.Asn1847= synonymous_variant 43/70 ENST00000224721.12 NP_071407.4

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CDH23ENST00000224721.12 linkuse as main transcriptc.5541C>T p.Asn1847= synonymous_variant 43/705 NM_022124.6 ENSP00000224721 P1Q9H251-1

Frequencies

GnomAD3 genomes
AF:
0.00141
AC:
214
AN:
152242
Hom.:
3
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.000265
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000916
Gnomad ASJ
AF:
0.00461
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.0213
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000852
Gnomad OTH
AF:
0.00478
GnomAD3 exomes
AF:
0.00279
AC:
695
AN:
249380
Hom.:
7
AF XY:
0.00350
AC XY:
474
AN XY:
135272
show subpopulations
Gnomad AFR exome
AF:
0.000193
Gnomad AMR exome
AF:
0.00110
Gnomad ASJ exome
AF:
0.00278
Gnomad EAS exome
AF:
0.0000556
Gnomad SAS exome
AF:
0.0166
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000955
Gnomad OTH exome
AF:
0.00148
GnomAD4 exome
AF:
0.00171
AC:
2503
AN:
1461712
Hom.:
25
Cov.:
33
AF XY:
0.00223
AC XY:
1621
AN XY:
727140
show subpopulations
Gnomad4 AFR exome
AF:
0.000149
Gnomad4 AMR exome
AF:
0.00103
Gnomad4 ASJ exome
AF:
0.00325
Gnomad4 EAS exome
AF:
0.0000504
Gnomad4 SAS exome
AF:
0.0165
Gnomad4 FIN exome
AF:
0.0000187
Gnomad4 NFE exome
AF:
0.000714
Gnomad4 OTH exome
AF:
0.00187
GnomAD4 genome
AF:
0.00141
AC:
215
AN:
152360
Hom.:
3
Cov.:
34
AF XY:
0.00168
AC XY:
125
AN XY:
74510
show subpopulations
Gnomad4 AFR
AF:
0.000264
Gnomad4 AMR
AF:
0.000915
Gnomad4 ASJ
AF:
0.00461
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.0216
Gnomad4 FIN
AF:
0.0000941
Gnomad4 NFE
AF:
0.000852
Gnomad4 OTH
AF:
0.00473
Alfa
AF:
0.000991
Hom.:
0
Bravo
AF:
0.000846
Asia WGS
AF:
0.00751
AC:
26
AN:
3478
EpiCase
AF:
0.00125
EpiControl
AF:
0.00148

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Benign, criteria provided, single submitterclinical testingGeneDxFeb 15, 2019This variant is associated with the following publications: (PMID: 12075507, 22135276, 29148562) -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Likely benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
not specified Benign:3
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Nov 17, 2014- -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineAug 26, 2015Asn1847Asn in exon 43 of CDH23: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue, is not located withi n the splice consensus sequence, and has been identified in 1.6% (269/16510) of South Asian chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.b roadinstitute.org; dbSNP rs148632119) -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Usher syndrome type 1 Benign:1
Benign, no assertion criteria providedclinical testingNatera, Inc.Dec 06, 2019- -
Usher syndrome type 1D Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. -
Autosomal recessive nonsyndromic hearing loss 12 Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.54
CADD
Benign
0.099
DANN
Benign
0.77

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs148632119; hg19: chr10-73544686; API